Description

Description

Galvecta Plus (50mg/1000mg) is a fixed-dose combination medicine manufactured by PharmaEvo, formulated with Vildagliptin 50mg and Metformin 1000mg in each tablet. This pack contains 14 tablets and represents the higher-strength Metformin variant within the Galvecta Plus range, intended for adults with type 2 diabetes mellitus whose blood sugar levels require a more substantial dose of Metformin alongside the DPP-4 inhibiting action of Vildagliptin. This combination is typically prescribed for patients who have already been stabilized on both individual components at these respective doses, or for those whose physician determines that a stronger Metformin component is necessary to achieve adequate glycemic control. Vildagliptin works by increasing levels of natural hormones that prompt the pancreas to release more insulin when blood sugar is high while also reducing glucose production by the liver, and it carries a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. Metformin complements this by further reducing hepatic glucose output and improving the body’s sensitivity to insulin. The combined action of these two mechanisms is intended to offer more comprehensive support for blood sugar management within a single tablet, reducing pill burden for patients on multi-drug regimens. As with all diabetes medications, Galvecta Plus should be used as part of a complete treatment plan that includes dietary control, physical activity, and regular monitoring, and only under continuous medical supervision.

Ingredients

Each tablet of Galvecta Plus (50/1000mg) contains two active pharmaceutical ingredients: Vildagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 1000mg, a biguanide-class antidiabetic agent that reduces hepatic glucose production and improves peripheral insulin sensitivity. The tablet also includes standard inactive excipients such as binders and film-coating agents, which help maintain the tablet’s structural stability and support consistent release of the active ingredients.

Dosage Form

Galvecta Plus (50/1000mg) is available as an oral film-coated tablet containing a combined strength of 50mg Vildagliptin and 1000mg Metformin per tablet. The pack includes 14 tablets, suited to prescription cycles as determined by a treating physician, and represents the higher Metformin strength within the Galvecta Plus range.

Uses

Galvecta Plus (50/1000mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly in patients who require a higher dose of Metformin in combination with Vildagliptin to achieve their target glycemic levels. It is generally prescribed when treatment with lower-strength combinations or Metformin alone has not sufficiently controlled blood sugar, and may be used together with other antidiabetic therapies as directed by a physician. This medicine is not intended for type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

Galvecta Plus tablets are typically taken twice daily with meals as directed by a doctor, to help minimize gastrointestinal side effects commonly associated with higher doses of Metformin. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically instructed by a healthcare provider. The prescribed dose and duration of treatment should be strictly followed, as they are tailored to individual factors such as kidney and liver function, current blood sugar control, and other medications being taken. If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

As with any medication, Galvecta Plus (50/1000mg) may cause side effects, and the higher Metformin content may make gastrointestinal effects more noticeable in some individuals, especially when treatment is first started. Commonly reported effects include nausea, diarrhea, stomach discomfort, and a metallic taste, along with dizziness and headache linked to the Vildagliptin component. Some patients may also experience mild joint discomfort. In rare cases, more serious effects such as lactic acidosis (associated with Metformin), significant liver problems, or pancreatitis (associated with Vildagliptin) may occur, and immediate medical attention should be sought if symptoms such as severe abdominal pain, unusual fatigue, persistent nausea, or yellowing of the skin or eyes develop.

Pregnancy & Breastfeeding

Galvecta Plus (50/1000mg) is generally not recommended during pregnancy. While Metformin has been used in certain pregnancy-related situations under close medical supervision, the safety of Vildagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor immediately. The safety of this combination during breastfeeding has not been well established, and alternative treatment approaches are usually considered for nursing mothers. Any use during pregnancy or breastfeeding should be decided only in consultation with a qualified healthcare provider.

Storage Instructions

Galvecta Plus tablets should be stored at room temperature, in a cool and dry place away from direct sunlight, heat, and excess moisture. Tablets should be kept in their original packaging until ready for use to protect them from environmental exposure. Store out of reach of children and pets, and do not use the medication past its printed expiry date. Unused or expired tablets should be disposed of responsibly according to local pharmaceutical disposal guidelines, rather than discarded with regular household waste.

FAQs

Why is there a 1000mg Metformin version of Galvecta Plus?
The higher strength is intended for patients who require a larger Metformin dose to achieve adequate blood sugar control, as determined by their doctor based on individual response to treatment.

Should I take this with food?
Yes, taking Galvecta Plus with meals is generally recommended to help reduce the gastrointestinal discomfort that can occur with higher Metformin doses.

Can I switch directly from a lower Galvecta Plus strength to this 1000mg version?
Any change in strength should only be made under a doctor’s guidance, as it may require dose titration and monitoring of blood sugar, kidney, and liver function.

Is this combination safe for long-term use?
Galvecta Plus can be used long-term as part of ongoing diabetes management, but it requires periodic monitoring of kidney and liver function and overall response, as advised by your healthcare provider.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.